Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Respiratory
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Vitamin K Antagonists Linked to Lower Short-Term Risk in COPD
February 2026
Nationwide cohort data suggest vitamin K antagonists are linked to a lower 1-year risk of severe COPD exacerbation or death compared with DOACs.
Read more
5 Feb 2026
Vitamin K Antagonists Linked to Lower Short-Term Risk in COPD
Nationwide cohort data suggest vitamin K antagonists are linked to a lower 1-year risk of severe COPD exacerbation or death compared with DOACs.
2 Feb 2026
Major Study Reveals New Genetic Links to Pneumonia
Study of over 600,000 people finds genetic differences influencing pneumonia risk across age, immunity, and smoking behaviour.
1 Feb 2026
Telomere Genetics Reshape Idiopathic Pulmonary Fibrosis Risk
Large genetic study links telomere-related polygenic risk to distinct idiopathic pulmonary fibrosis subgroups, improving disease prediction.
30 Jan 2026
Does Bisoprolol Benefit Patients with COPD?
A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite their high cardiovascular risk.
26 Jan 2026
Low Vitamin D Tied to Respiratory Infection Hospital Risk
UK Biobank study links very low vitamin D levels with higher risk of hospital admission for respiratory tract infections across ethnic groups.
25 Jan 2026
New Blood Marker Predicts Future Asthma Attacks
Sphingolipid-to-steroid ratios in blood accurately predict asthma attacks years in advance, offering a new precision medicine tool for asthma care.
24 Jan 2026
GLP-1RAs Reduce Asthma Attacks in Adolescents with Obesity
Teens with obesity using GLP-1RAs experienced fewer asthma exacerbations, emergency visits, and steroid prescriptions compared with nonpharmacological weight management.
22 Jan 2026
School Tobacco Prevention Cuts Youth Smoking Rates
Expanded school tobacco prevention in California schools was linked to lower adolescent tobacco use in a large, state-representative survey.
Loading posts...
1
2
3
…
45
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View